StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 10/17/2013 -- StockRunway.com issues special report on –EXCO Resources Inc (NYSE:XCO), Transurban Group (ASX:TCL), GT Advanced Technologies Inc (NASDAQ:GTAT), Myriad Genetics, Inc. (NASDAQ:MYGN).
EXCO Resources Inc (NYSE:XCO) increased 4.80% and closed at $7.20 on a traded volume of 2.96 million shares, in comparison to 2.80 million shares of average trading volume.
The company has a total market capitalization of $1.57 billion and its total outstanding shares are 217.55 million. EXCO Resources, Inc., an independent oil and natural gas company, engages in the acquisition, exploration, exploitation, development and production of onshore U.S.
Will XCO Continue To Move Higher? Find Out Here
Transurban Group (ASX:TCL) plunged -1.40% and closed at $7.02 on a traded volume of 4.17 million shares, whereas its average trading volume is 4.02 million shares. The Intra-day range for the stock is $7.01 and $7.19. Transurban Group is engaged in the business of development, operation and maintenance of toll roads. The Company has three geographic segments: Victoria, Australia; New South Wales, Australia and the United States of America (USA).
Will TCL Get Buyers Even After The Recent Rally? Find Out Here
GT Advanced Technologies Inc (NASDAQ:GTAT) jumped 2.59% and closed at $8.31. The 52-week range for the stock is $2.61 and $9.22 and during the previous trading session the stock touched its highest price at $8.34. Its introductory price for the day was $8.16, with the overall traded volume of 9.22 million shares. GT Advanced Technologies Inc. provides crystal growth equipment and solutions for the solar, light emitting diode (LED), and electronics industries worldwide.
Will GTAT Continue To Move Higher? Find Out Here
Myriad Genetics, Inc. (NASDAQ:MYGN) after opening its trade at the price of $23.37, jumped 0.26% to close at $23.30 for the day. The stock moved on a traded volume of 2.57 million shares, in comparison to 2.67 million shares of average trading volume. The 52-week range for the stock is $22.20 and $38.27 and during the previous trading session the stock touched its highest price at $23.69. Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive medicine, personalized medicine, and prognostic medicine tests primarily in the United States.
Will MYGN Continue To Move Higher? Find Out Here
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)